#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA1108920	Binding	Inhibition of human SGLT2 expressed in CHOK1 cells assessed as inhibition of glucose uptake	Homo sapiens	20	ALA1156151	cell-based format	Scientific Literature
2.	ALA1108921	Binding	Inhibition of human SGLT1 expressed in CHOK1 cells assessed as inhibition of glucose uptake	Homo sapiens	20	ALA1156151	cell-based format	Scientific Literature
3.	ALA1108922	Binding	Selectivity ratio of IC50 for human SGLT1 to IC50 for human SGLT2	Homo sapiens	20	ALA1156151	assay format	Scientific Literature
4.	ALA1108923	Functional	Antihyperglycemic activity in Sprague-Dawley rat assessed as inhibition of streptozotocin-induced increase in blood glucose level at 0.3 to 3 mg/kg, po	Rattus norvegicus	5	ALA1156151	organism-based format	Scientific Literature
5.	ALA1108924	ADME	Metabolic stability in human liver microsomes assessed as compound remaining at 5 umol/L after 15 mins by LC/MS/MS analysis	Homo sapiens	6	ALA1156151	microsome format	Scientific Literature
6.	ALA1108925	ADME	Metabolic stability in cryopreserved human hepatocytes assessed as compound remaining at 5 umol/L after 240 mins by LC/MS/MS analysis	Homo sapiens	6	ALA1156151	cell-based format	Scientific Literature
7.	ALA1108928	ADME	Protein binding in human serum at 1 ug/ml	Homo sapiens	5	ALA1156151	cell-free format	Scientific Literature
8.	ALA1108929	ADME	Cmax in rat at 1 mg/kg, po and 1 mg/kg, iv	Rattus norvegicus	1	ALA1156151	organism-based format	Scientific Literature
9.	ALA1108930	ADME	Tmax in rat at 1 mg/kg, po and 1 mg/kg, iv	Rattus norvegicus	1	ALA1156151	organism-based format	Scientific Literature
10.	ALA1108931	ADME	Half life in rat at 1 mg/kg, po and 1 mg/kg, iv	Rattus norvegicus	1	ALA1156151	organism-based format	Scientific Literature
11.	ALA1108932	ADME	Oral bioavailability in rat at 1 mg/kg	Rattus norvegicus	1	ALA1156151	organism-based format	Scientific Literature
12.	ALA1108933	ADME	Volume of distribution at steady state in rat at 1 mg/kg, po and 1 mg/kg, iv	Rattus norvegicus	1	ALA1156151	organism-based format	Scientific Literature
13.	ALA1108934	ADME	Clearance in rat at 1 mg/kg, po and 1 mg/kg, iv	Rattus norvegicus	1	ALA1156151	organism-based format	Scientific Literature
14.	ALA1108935	ADME	Cmax in dog at 1 mg/kg, po and 1 mg/kg, iv	Canis lupus familiaris	1	ALA1156151	organism-based format	Scientific Literature
15.	ALA1108936	ADME	Tmax in dog at 1 mg/kg, po and 1 mg/kg, iv	Canis lupus familiaris	1	ALA1156151	organism-based format	Scientific Literature
16.	ALA1108937	ADME	Half life in dog at 1 mg/kg, po and 1 mg/kg, iv	Canis lupus familiaris	1	ALA1156151	organism-based format	Scientific Literature
17.	ALA1108938	ADME	Oral bioavailability in dog at 1 mg/kg	Canis lupus familiaris	1	ALA1156151	organism-based format	Scientific Literature
18.	ALA1108939	ADME	Volume of distribution at steady state in dog at 1 mg/kg, po and 1 mg/kg, iv	Canis lupus familiaris	1	ALA1156151	organism-based format	Scientific Literature
19.	ALA1108940	ADME	Clearance in dog at 1 mg/kg, po and 1 mg/kg, iv	Canis lupus familiaris	1	ALA1156151	organism-based format	Scientific Literature
20.	ALA1108947	ADME	Drug level in rat plasma at 1 mg/kg, po after 1 hr	Rattus norvegicus	1	ALA1156151	organism-based format	Scientific Literature